EGFR Peptide (human, mouse) (myristoylated) TFA

This myristoylated EGFR peptide is a synthetic PKC inhibitor (IC50 = 5 μM) derived from the intracellular EGFR sequence. It is used in cancer research, particularly for studying multidrug resistance, as it can reverse doxorubicin resistance in fibrosarcoma cell lines like UV-2237M-ADRR at 1 μM concentrations.